Gemini Therapeutics Inc
NASDAQ:GMTX
Income Statement
Earnings Waterfall
Gemini Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-47.5m
USD
|
Operating Income
|
-47.5m
USD
|
Other Expenses
|
648k
USD
|
Net Income
|
-46.8m
USD
|
Income Statement
Gemini Therapeutics Inc
Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|
Revenue | ||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||
Operating Expenses |
(1)
|
(69)
|
(47)
|
|
Selling, General & Administrative |
(1)
|
(20)
|
(14)
|
|
Research & Development |
0
|
(49)
|
(33)
|
|
Other Operating Expenses |
0
|
0
|
0
|
|
Operating Income |
(1)
N/A
|
(69)
-8 356%
|
(47)
+31%
|
|
Pre-Tax Income | ||||
Interest Income Expense |
0
|
(2)
|
1
|
|
Non-Reccuring Items |
0
|
(1)
|
0
|
|
Total Other Income |
0
|
(0)
|
0
|
|
Pre-Tax Income |
(1)
N/A
|
(72)
-8 745%
|
(47)
+35%
|
|
Net Income | ||||
Tax Provision |
0
|
0
|
0
|
|
Income from Continuing Operations |
(1)
|
(72)
|
(47)
|
|
Net Income (Common) |
(1)
N/A
|
(72)
-8 745%
|
(47)
+35%
|
|
EPS (Diluted) |
-0.53
N/A
|
-17.81
-3 260%
|
-2.69
+85%
|